Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline
X. Kostaras, MSc,* F. Cusano, BSc Pharm,? G.A. Kline, MD,? W. Roa, MD,§ and J. Easaw, MD PhD‖, the AlbertaProvincial CNS Tumour Team
Curr Oncol. Jun 2014; 21(3): e493–e503.
Recommendations Based on the evidence available to date, the Alberta Provincial CNS Tumour Team makes these recommendations: Treatment with dexamethasone is recommended for symptom relief in adult patients with primary high-grade glioma and cerebral edema.
针对成人原发性高度恶性胶质瘤以及脑水肿,建议给予地塞米松来缓解症状。
After surgery, a maximum dose of 16 mg daily, administered in 4 equal doses, is recommended for symptomatic patients. This protocol should ideally be started by the neurosurgeon. 对于有症状的病人,手术之后,每日16mg,分四次给予。
A rapid dexamethasone tapering schedule should be considered where appropriate. 合适的时候,快速的减少地塞米松是应当要考虑的
Patients who have high-grade tumours, are symptomatic, or have poor life expectancy, can be maintained on a 0.5–1.0 mg dose of dexamethasone daily.对于有症状的患有高度恶性胶质瘤的患者,建议每日给予0.5-1.0mg地塞米松的维持剂量。
Side effects with dexamethasone are common, and they increase in frequency and severity with increased dose and duration of therapy. Patients should be carefully monitored for endocrine, muscular, skeletal, gastrointestinal, psychiatric, and hematologic complications, and for infections and other general side effects. 地塞米松的副作用很常见。并且随着剂量和使用时间的延长,副作用发生的频率和严重程度都在增加。应当严密监测内分泌,肌肉系统,骨骼,胃肠道,精神状态,血液学方面的并发症,感染以及其它普通的副作用也需要监测。